Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJXF5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,908
Award facts
- Contract value 100% obligated
- $2,908.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,908.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200-unit vials. The delivery order, issued on January 7, 2026, with an ultimate completion date of January 29, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the awardee under its existing Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors supplying pharmaceutical products to Department of Defense healthcare facilities worldwide.
This delivery order represents a routine pharmaceutical procurement under DMS Pharmaceutical Group's single-award IDC designated SPE2DR, which was awarded in November 2025 with a $499,999,999 ceiling value and completion date of December 31, 2036. The contract structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support military healthcare operations globally. DMS Pharmaceutical Group's established performance across numerous previous delivery orders demonstrates its capability as a critical pharmaceutical supplier within the federal military medical supply chain, with the company's comprehensive product portfolio encompassing specialty pharmaceuticals, biologics, vaccines, and medical consumables serving diverse therapeutic requirements.
Quick answers
Who was awarded contract SPE2DR26FJXF5?
SPE2DR26FJXF5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FJXF5 worth?
The government has obligated $2,908 on SPE2DR26FJXF5.
Is contract SPE2DR26FJXF5 an order under another contract?
Yes. SPE2DR26FJXF5 is a delivery order under SPE2DR25D9307, an indefinite delivery contract.
Was contract SPE2DR26FJXF5 competed?
The extent of competition for SPE2DR26FJXF5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award